155 related articles for article (PubMed ID: 30820547)
1. Biclustering analysis of transcriptome big data identifies condition-specific microRNA targets.
Yoon S; Nguyen HCT; Jo W; Kim J; Chi SM; Park J; Kim SY; Nam D
Nucleic Acids Res; 2019 May; 47(9):e53. PubMed ID: 30820547
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
[TBL] [Abstract][Full Text] [Related]
4. In Silico Integration Approach Reveals Key MicroRNAs and Their Target Genes in Follicular Thyroid Carcinoma.
Hu S; Liao Y; Zheng J; Gou L; Regmi A; Zafar MI; Chen L
Biomed Res Int; 2019; 2019():2725192. PubMed ID: 31032340
[TBL] [Abstract][Full Text] [Related]
5. The PI3K/AKT signaling pathway: Associations of miRNAs with dysregulated gene expression in colorectal cancer.
Slattery ML; Mullany LE; Sakoda LC; Wolff RK; Stevens JR; Samowitz WS; Herrick JS
Mol Carcinog; 2018 Feb; 57(2):243-261. PubMed ID: 29068474
[TBL] [Abstract][Full Text] [Related]
6. MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway.
Ishibashi O; Akagi I; Ogawa Y; Inui T
Biochem Biophys Res Commun; 2018 Jun; 501(2):507-513. PubMed ID: 29738771
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of directly captured microRNA targets reveals the impact of microRNAs on mammalian transcriptome.
Bjerke GA; Yi R
RNA; 2020 Mar; 26(3):306-323. PubMed ID: 31900330
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients.
Lim EL; Trinh DL; Scott DW; Chu A; Krzywinski M; Zhao Y; Robertson AG; Mungall AJ; Schein J; Boyle M; Mottok A; Ennishi D; Johnson NA; Steidl C; Connors JM; Morin RD; Gascoyne RD; Marra MA
Genome Biol; 2015 Jan; 16(1):18. PubMed ID: 25723320
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
12. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
[TBL] [Abstract][Full Text] [Related]
13. Systems biology approach identifies key regulators and the interplay between miRNAs and transcription factors for pathological cardiac hypertrophy.
Recamonde-Mendoza M; Werhli AV; Biolo A
Gene; 2019 May; 698():157-169. PubMed ID: 30844478
[TBL] [Abstract][Full Text] [Related]
14. Denoising perturbation signatures reveal an actionable AKT-signaling gene module underlying a poor clinical outcome in endocrine-treated ER+ breast cancer.
Teschendorff AE; Li L; Yang Z
Genome Biol; 2015 Apr; 16(1):61. PubMed ID: 25886003
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics Analysis Identifies MicroRNAs and Target Genes Associated with Prognosis in Patients with Melanoma.
Li Q; Zhang LY; Wu S; Huang C; Liu J; Wang P; Cao Y
Med Sci Monit; 2019 Oct; 25():7784-7794. PubMed ID: 31621692
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
17. Crucial microRNAs and genes of human primary breast cancer explored by microRNA-mRNA integrated analysis.
Yang Y; Xing Y; Liang C; Hu L; Xu F; Chen Y
Tumour Biol; 2015 Jul; 36(7):5571-9. PubMed ID: 25680412
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-432 targeting E2F3 and P55PIK inhibits myogenesis through PI3K/AKT/mTOR signaling pathway.
Ma M; Wang X; Chen X; Cai R; Chen F; Dong W; Yang G; Pang W
RNA Biol; 2017 Mar; 14(3):347-360. PubMed ID: 28085550
[TBL] [Abstract][Full Text] [Related]
19. HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma.
Jia YJ; Liu ZB; Wang WG; Sun CB; Wei P; Yang YL; You MJ; Yu BH; Li XQ; Zhou XY
Leukemia; 2018 Mar; 32(3):703-711. PubMed ID: 29135973
[TBL] [Abstract][Full Text] [Related]
20. A novel biclustering algorithm for the discovery of meaningful biological correlations between microRNAs and their target genes.
Pio G; Ceci M; D'Elia D; Loglisci C; Malerba D
BMC Bioinformatics; 2013; 14 Suppl 7(Suppl 7):S8. PubMed ID: 23815553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
